PERRY DAVID P
Insider CIK 1105941 · ANAC President and CEO, Director · EVLO Director · BTTX See Remarks, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BTTX Better Therapeutics, Inc. | A Award | 2024-02-09 | 2024-02-13 | 839,895 | $0.19 | $159.6K | 2,416,634 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award | 2024-01-09 | 2024-01-10 | 1,471,453 | $0.17 | $250.1K | 1,576,739 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award | 2023-12-18 | 2023-12-20 | 3,750 | — | $0 | 105,286 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2023-07-27 | 2023-07-31 | 1,233,045 | $0.73 | $900.1K | 13,030,393 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2023-04-10 | 2023-04-12 | 1,333,333 | $0.83 | $1.11M | 11,797,348 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2023-04-10 | 2023-04-12 | 3,636,364 | $0.83 | $3.02M | 3,636,364 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-19 | 39,156 | $2.07 | $81.1K | 101,536 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2022-09-15 | 2022-09-19 | 10,844 | $1.99 | $21.6K | 62,380 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award deriv | 2021-10-28 | 2021-11-01 | 28,300 | — | $0 | 28,300 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award | 2021-10-28 | 2021-11-01 | 100,000 | $10.00 | $1.00M | 10,830,037 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2021-10-28 | 2021-11-01 | 200,000 | $10.00 | $2.00M | 10,730,037 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award | 2021-10-28 | 2021-11-01 | 21,336 | — | $0 | 10,530,037 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award | 2021-10-28 | 2021-11-01 | 293,150 | — | $0 | 10,508,701 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award | 2021-10-28 | 2021-11-01 | 10,164,015 | — | $0 | 10,215,551 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2021-06-09 | 2021-06-11 | 1,810 | — | $0 | 1,810 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2021-06-08 | 2021-06-11 | 15,690 | — | $0 | 15,690 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2021-05-26 | 2021-11-01 | 20,000 | $9.95 | $199.0K | 51,536 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2021-05-24 | 2021-11-01 | 8,000 | $9.94 | $79.5K | 31,536 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2021-05-21 | 2021-11-01 | 8,000 | $9.95 | $79.6K | 23,536 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2021-05-14 | 2021-11-01 | 3,060 | $9.93 | $30.4K | 15,536 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2021-05-13 | 2021-11-01 | 7,000 | $9.93 | $69.5K | 12,476 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2021-05-04 | 2021-11-01 | 3,476 | $9.93 | $34.5K | 5,476 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2021-04-30 | 2021-11-01 | 2,000 | $9.95 | $19.9K | 2,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2020-06-17 | 2020-06-18 | 15,690 | — | $0 | 15,690 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2019-06-12 | 2019-06-13 | 15,690 | — | $0 | 15,690 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-03-05 | 2014-03-06 | 7,500 | $20.24 | $151.8K | 361,306 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-03-04 | 2014-03-06 | 50,000 | $20.22 | $1.01M | 368,806 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-03-04 | 2014-03-06 | 7,500 | $20.20 | $151.5K | 418,806 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-02-07 | 2014-02-10 | 165,000 | — | $0 | 165,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-02-05 | 2014-02-05 | 7,500 | $16.71 | $125.3K | 426,306 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-02-04 | 2014-02-05 | 7,500 | $17.29 | $129.7K | 433,806 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-01-09 | 2014-01-09 | 7,500 | $16.49 | $123.7K | 441,306 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-01-08 | 2014-01-09 | 7,500 | $16.30 | $122.3K | 498,806 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-01-08 | 2014-01-09 | 50,000 | $16.30 | $815.0K | 448,806 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2013-12-09 | 2013-12-09 | 285,480 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2013-12-09 | 2013-12-09 | 285,480 | $0.60 | $171.3K | 516,634 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2013-12-09 | 2013-12-09 | 10,328 | $16.72 | $172.7K | 506,306 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2013-12-06 | 2013-12-09 | 9,800 | $16.99 | $166.5K | 231,154 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2013-12-06 | 2013-12-09 | 5,200 | $16.58 | $86.2K | 240,954 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2013-12-05 | 2013-12-09 | 12,100 | $15.18 | $183.7K | 249,054 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2013-12-05 | 2013-12-09 | 2,900 | $15.67 | $45.4K | 246,154 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2013-04-12 | 2013-04-16 | 185,000 | — | $0 | 185,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | A Award deriv | 2012-03-13 | 2012-03-14 | 125,000 | — | $0 | 125,000 | SEC↗ |